急性心肌梗死后继发室性心律失常应用胺碘酮对比利多卡因的临床效果研究

Clinical effect of amiodarone and lidocaine in the treatment of secondary ventricular arrhythmias after acute myocardial infarction

目的:探讨胺碘酮与利多卡治疗急性心肌梗死后继发室性心律失常的临床效果与安全性。方法:收治急性心肌梗死后继发室性心律失常患者84例,随机分为对照组与研究组,在常规治疗基础上,两组分别应用利多卡因和胺碘酮治疗,比较两组临床效果与安全性。结果:研究组临床总好转率和不良反应发生率均明显优于对照组(P<0.05)。结论:胺碘酮治疗急性心肌梗死后继发室性心律失常的临床效果和安全性优于利多卡因。

Objective:To explore the clinical effect and security of amiodarone and lidocaine in the treatment of secondary ventricular arrhythmias after acute myocardial infarction.Methods:84 patients with secondary ventricular arrhythmias after acute myocardial infarction were selected.They were randomly divided into the control group and the study group.On the basis of routine treatment,two groups were given lidocaine and amiodarone treatment respectively.The clinical effect and safety of two groups we compared.Results:In the study group,the total improvement rate and the incidence of adverse reaction were significantly better than those in the control group(P<0.05).Conclusion:The clinical effect and security of amiodarone in the treatment of secondary ventricular arrhythmias after acute myocardial infarction were better than lidocaine.